Castle Biosciences (CSTL) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 6, 2023 (09:14)Sector: Healthcare
The share price of Castle Biosciences, Inc. (CSTL) now
50/200 Day Moving Average: $16.13 / $19.01
This figure corresponds to the Average Price over the previous 50/200 days. For Castle Biosciences stocks, the 50-day moving average is the support level today.
For Castle Biosciences stocks, the 200-day moving average is the support level today.
Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Castle Biosciences share be worth in 2024 - 2028?
When should I take profit in Castle Biosciences stock? When should I record a loss on Castle Biosciences stock? What are analysts' forecasts for Castle Biosciences stock? What is the future of Castle Biosciences stock? We forecast Castle Biosciences stock performance using neural networks based on historical data on Castle Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Castle Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Castle Biosciences shares. This happens once a day.
Historical and forecast chart of Castle Biosciences stock
The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Castle Biosciences stock price can be found in the table below.
Long-term forecasts by years.
Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Castle Biosciences daily forecast for a month
Castle Biosciences Daily Price Targets
Castle Biosciences Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $20.20.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 5.556%.
Pessimistic target level: 19.65
Optimistic target level: 20.80
Castle Biosciences Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $20.37.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 6.088%.
Pessimistic target level: 19.74
Optimistic target level: 21.02
Castle Biosciences Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $20.70.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 5.603%.
Pessimistic target level: 20.09
Optimistic target level: 21.28
Castle Biosciences Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $20.08.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 2.657%.
Pessimistic target level: 19.72
Optimistic target level: 20.26
Castle Biosciences Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $20.38.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.751%.
Pessimistic target level: 19.94
Optimistic target level: 20.94
Castle Biosciences Stock Forecast 12-13-2023.
Forecast target price for 12-13-2023: $20.42.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 3.902%.
Pessimistic target level: 20.11
Optimistic target level: 20.93
CSTL (CSTL) Monthly Stock Prediction for 2024
Castle Biosciences forecast for this year
Castle Biosciences Stock Prediction for Jan 2024
An uptrend is forecast for this month with an optimal target price of $21.0535. Pessimistic: $19.82. Optimistic: $22.62
Castle Biosciences Stock Prediction for Feb 2024
An uptrend is forecast for this month with an optimal target price of $22.3504. Pessimistic: $20.29. Optimistic: $23.23
Castle Biosciences Stock Prediction for Mar 2024
An uptrend is forecast for this month with an optimal target price of $22.851. Pessimistic: $20.45. Optimistic: $24.80
Castle Biosciences Stock Prediction for Apr 2024
An downtrend is forecast for this month with an optimal target price of $22.3711. Pessimistic: $20.87. Optimistic: $24.25
Castle Biosciences Stock Prediction for May 2024
An downtrend is forecast for this month with an optimal target price of $21.4316. Pessimistic: $19.30. Optimistic: $23.41
Castle Biosciences Stock Prediction for Jun 2024
An downtrend is forecast for this month with an optimal target price of $20.7415. Pessimistic: $19.99. Optimistic: $21.90
Castle Biosciences Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $21.2641. Pessimistic: $20.10. Optimistic: $22.10
Castle Biosciences Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $20.9069. Pessimistic: $19.85. Optimistic: $22.08
Castle Biosciences Stock Prediction for Sep 2024
An uptrend is forecast for this month with an optimal target price of $21.9313. Pessimistic: $21.13. Optimistic: $22.61
Castle Biosciences Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $24.7254. Pessimistic: $23.34. Optimistic: $26.91
Castle Biosciences Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $25.8677. Pessimistic: $23.26. Optimistic: $27.61
Castle Biosciences Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $25.3969. Pessimistic: $23.80. Optimistic: $27.28
Castle Biosciences (CSTL) Monthly Stock Prediction for 2025
Castle Biosciences (CSTL) Monthly Stock Prediction for 2026
Castle Biosciences (CSTL) Monthly Stock Prediction for 2027
Castle Biosciences (CSTL) Monthly Stock Prediction for 2028
Castle Biosciences information and performance
820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US
Market capitalization of the Castle Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CSTL shares in the company outstanding by the market price of one share.
EBITDA of Castle Biosciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.